Login
  • In Depth
  • Earnings
    Search Calendar Annual Comparison Quarterly Comparison Quarterly Range Growth Rate Sector View Earnings Averages P/E Ratio Annual Fiscal Year Dividend Frequency
  • Stocks
    Annual Returns 52 Week High/Low Advanced Search Advanced Screen 52 Wk HL Screen Financial Ratios Indexes Sectors Market Updates IPOs SEC Filings Market Cap
  • Funds
    Mutual Funds
    Funds - Family
    Q&A - Fund Family
    Q&A - Date
    Performance By Category
    Performance Screen
    Alpha Screen
    Time Period Screen
    52 Wk Mutual Funds HL Screen
    Manager Database
    ETFs
    Funds - Family
    Performance By Category
    Performance Screen
    Alpha Screen
    Time Period Screen
    52 Wk ETF HL Screen
  • Economy
    U.S.        - Feed Europe  - Feed U.S.        - Chart Europe  - Chart Currencies
  • Books
  • Weekly Review
  • Log In Sign Up
Breaking News
FactSet Research   Lennar   FedEx Corp   Scholastic   Darden Restaurants   Cracker Barrel   Hain Celestial   Dave & Buster’s   Designer Brands  
  • Jan
  • Feb
  • Mar
  • Apr
  • May
  • Jun
  • Jul
  • Aug
  • Sep
  • Oct
  • Nov
  • Dec
  • Sector
  • Technology
  • Health Care
  • Transportation
  • Manufacturing
  • Popular Earnings
  • Deutsche Bank
  • Adobe
  • Google
  • Apple
  • Microsoft
  • Facebook
  • General Electric
  • Amazon
  • Boeing
  • Delta Airlines

Market Updates

Fresenius Medical Care increased 0.4% to €27.71 after the dialysis service provider lifted its annual outlook.

Revenue in the third quarter declined 3% to €4.9 billion from €5.03 billion, net income fell to €84 million from €230 million, and net income dropped to 29 cents from 7 cents a year ago.

The company reiterated its 2023 revenue to grow at a low to mid-single-digit percentage rate from €19.4 billion in 2022.

The company raised its 2023 operating earnings to grow at a low single-digit percentage rate from €1.54 billion in 2022, from the previous outlook of flat to a decline in the low single-digit percentage rate.

The German company also said it had resolved its legal dispute with the U.S. Department of Defense and finalized its settlement for payment of dialysis services provided under the Tricare program to members of military service, their dependents, and retirees.

The company sought to receive payment for services provided under the Tricare program on or before January 11, 2023.

As a consequence of the settlement agreement, Fresenius anticipates a positive impact on operating income of €175 million in the fourth quarter.


22 Nov, 2023

     

Annual Returns

Company Ticker 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008

Earnings

Company Ticker 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008

Custom Solutions

  • Portfolio Management
  • Strategy Analysis
  • Data Feed Integration
  • Investment Process Evaluator

Advertisers

  • Sponsorship
  • Preferred Listing
  • Newsletter Placement
  • Lead Generator

Newsletter

  • Sign Up
  • Monthly Performance Update

Investor

  • Profile
  • Watch List
  • Portfolio

Site Pages

  • About Us
  • Contact Us
  • User Agreement
  • Subscribe
  • Newsletter
  • API and News Feeds

© Since 2000 ticker.com All Rights Reserved



Mutual Fund and ETF profiles, Manager Interviews Tickerfunds.com
Global Financial News
123jump.com
India Business News, Stocks and Funds
Niveshak.in
Worldwide Trade Shows and Conferences
EventsXPO.com
Non-fiction Books, Booklists, Authors, Interviews Readara.com
Land and Home Buyers, Sellers, and Service Providers Zacres.com